North America Infectious Respiratory Disease Diagnostics Market Size, Share & Industry Trends Analysis Report By Product Type, By Application, By Sample Type, By Technology (Molecular Diagnostics, Microbiology, Immunoassay), By End-use, By Country and Growth Forecast, 2022 - 2028

The North America Infectious Respiratory Disease Diagnostics Market would witness market growth of -5.8% CAGR during the forecast period (2022-2028).

The demand for diagnostic tests is growing as a result of the rise in lower respiratory infectious disease, which increases the need for early detection. Likewise, the healthcare industry is experiencing an increase in public-private funding for targeted research initiatives. Also, the number of smokers and drinkers, as well as product innovations and development due to technological advancements all over the world is growing continuously and is anticipated to grow further over the forecast period.

In the future, the market's growth rate will be further accelerated by factors such as unhealthy individual lifestyles, rising internet penetration rates, an ageing population base, an increase in pollution levels, product development and commercialization, and rising per capita health care spending. A common condition, respiratory tract infections can be asymptomatic or present as a minor sickness that progresses to cause major problems, hospitalization, or even death.

Respiratory infections are frequently brought on by influenza and other viral diseases such as adenovirus, respiratory syncytial virus, human metapneumovirus, and rhinovirus. To stop and lessen the transmission of the influenza virus, early detection and diagnosis of the viral infection may enable the proper therapy to be started.

Almost 5 million children and nearly 15 million adults in America currently suffer from asthma. Since 1980, the percentage of asthma cases has nearly doubled. Asthma-related deaths affect 5,500 people annually, and over the past 20 years, the rate has risen. Also, due to the rising burden of COVID-19, a strong health care system, and rising rates of whooping cough, influenza, and other respiratory infections, the demand for respiratory disease.

The US market dominated the North America Infectious Respiratory Disease Diagnostics Market by Country in 2021; thereby, achieving a market value of $7.8 billion by 2028. The Canada market is experiencing a CAGR of -3.6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of -4.5% during (2022 - 2028).

Based on Product Type, the market is segmented into Consumables, Instruments (Imaging Tests, Respiratory Measurement Devices, and Others), Services. Based on Application, the market is segmented into SARS/COVID 19, Influenza, RSV (Respiratory Syncytial Virus), Tuberculosis, Streptococcus Testing, and Others. Based on Sample Type, the market is segmented into Saliva, Anterior Nasal Region, Blood, Nasopharyngeal Swabs (NPS), and Others. Based on Technology, the market is segmented into Molecular Diagnostics, Microbiology, Immunoassay, and Others. Based on End-use, the market is segmented into Diagnostic Laboratories, Hospitals, and Physician Offices & Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Free Valuable Insights: The Global Infectious Respiratory Disease Diagnostics Market is Estimated to reach $ 37.2 Billion by 2028, at a CAGR of -5.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Qiagen N.V., Bio-Rad Laboratories, Inc., Danaher Corporation, Quidel Corporation

Scope of the Study

Market Segments Covered in the Report:

By Product Type

• Consumables
• Instruments
  • Imaging Tests
  • Respiratory Measurement Devices
  • Others
• Services

By Application

• SARS/COVID 19
• Influenza
• RSV (Respiratory Syncytial Virus)
• Tuberculosis
• Streptococcus Testing
• Others

By Sample Type

• Saliva
• Anterior Nasal Region
• Blood
• Nasopharyngeal Swabs (NPS)
• Others

By Technology

• Molecular Diagnostics
• Microbiology
• Immunoassay
• Others

By End Use

• Diagnostic Laboratories
• Hospitals
• Physician Offices & Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Abbott Laboratories
• Becton, Dickinson and Company
• Siemens Healthineers AG (Siemens AG)
• Thermo Fisher Scientific, Inc.
• Koninklijke Philips N.V.
• F. Hoffmann-La Roche Ltd.
• Qiagen N.V.
• Bio-Rad Laboratories, Inc.
• Danaher Corporation
• Quidel Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Infectious Respiratory Disease Diagnostics Market, by Product Type
1.4.2 North America Infectious Respiratory Disease Diagnostics Market, by Application
1.4.3 North America Infectious Respiratory Disease Diagnostics Market, by Sample Type
1.4.4 North America Infectious Respiratory Disease Diagnostics Market, by Technology
1.4.5 North America Infectious Respiratory Disease Diagnostics Market, by End Use
1.4.6 North America Infectious Respiratory Disease Diagnostics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansion
3.2.5 Approval & Trails:
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Mar – 2022, Jun) Leading Players

Chapter 4. North America Infectious Respiratory Disease Diagnostics Market by Product Type
4.1 North America Consumables Market by Country
4.2 North America Instruments Market by Country
4.3 North America Infectious Respiratory Disease Diagnostics Market by Instruments Type
4.3.1 North America Imaging Tests Market by Country
4.3.2 North America Respiratory Measurement Devices Market by Country
4.3.3 North America Others Market by Country
4.4 North America Services Market by Country

Chapter 5. North America Infectious Respiratory Disease Diagnostics Market by Application
5.1 North America SARS/COVID 19 Market by Country
5.2 North America Influenza Market by Country
5.3 North America RSV (Respiratory Syncytial Virus) Market by Country
5.4 North America Tuberculosis Market by Country
5.5 North America Streptococcus Testing Market by Country
5.6 North America Others Market by Country

Chapter 6. North America Infectious Respiratory Disease Diagnostics Market by Sample Type
6.1 North America Saliva Market by Country
6.2 North America Anterior Nasal Region Market by Country
6.3 North America Blood Market by Country
6.4 North America Nasopharyngeal Swabs (NPS) Market by Country
6.5 North America Others Market by Country

Chapter 7. North America Infectious Respiratory Disease Diagnostics Market by Technology
7.1 North America Molecular Diagnostics Market by Country
7.2 North America Microbiology Market by Country
7.3 North America Immunoassay Market by Country
7.4 North America Others Market by Country

Chapter 8. North America Infectious Respiratory Disease Diagnostics Market by End-use
8.1 North America Diagnostic Laboratories Market by Country
8.2 North America Hospitals Market by Country
8.3 North America Physician Offices & Others Market by Country

Chapter 9. North America Infectious Respiratory Disease Diagnostics Market by Country
9.1 US Infectious Respiratory Disease Diagnostics Market
9.1.1 US Infectious Respiratory Disease Diagnostics Market by Product Type
9.1.1.1 US Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.1.2 US Infectious Respiratory Disease Diagnostics Market by Application
9.1.3 US Infectious Respiratory Disease Diagnostics Market by Sample Type
9.1.4 US Infectious Respiratory Disease Diagnostics Market by Technology
9.1.5 US Infectious Respiratory Disease Diagnostics Market by End-use
9.2 Canada Infectious Respiratory Disease Diagnostics Market
9.2.1 Canada Infectious Respiratory Disease Diagnostics Market by Product Type
9.2.1.1 Canada Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.2.2 Canada Infectious Respiratory Disease Diagnostics Market by Application
9.2.3 Canada Infectious Respiratory Disease Diagnostics Market by Sample Type
9.2.4 Canada Infectious Respiratory Disease Diagnostics Market by Technology
9.2.5 Canada Infectious Respiratory Disease Diagnostics Market by End-use
9.3 Mexico Infectious Respiratory Disease Diagnostics Market
9.3.1 Mexico Infectious Respiratory Disease Diagnostics Market by Product Type
9.3.1.1 Mexico Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.3.2 Mexico Infectious Respiratory Disease Diagnostics Market by Application
9.3.3 Mexico Infectious Respiratory Disease Diagnostics Market by Sample Type
9.3.4 Mexico Infectious Respiratory Disease Diagnostics Market by Technology
9.3.5 Mexico Infectious Respiratory Disease Diagnostics Market by End-use
9.4 Rest of North America Infectious Respiratory Disease Diagnostics Market
9.4.1 Rest of North America Infectious Respiratory Disease Diagnostics Market by Product Type
9.4.1.1 Rest of North America Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.4.2 Rest of North America Infectious Respiratory Disease Diagnostics Market by Application
9.4.3 Rest of North America Infectious Respiratory Disease Diagnostics Market by Sample Type
9.4.4 Rest of North America Infectious Respiratory Disease Diagnostics Market by Technology
9.4.5 Rest of North America Infectious Respiratory Disease Diagnostics Market by End-use

Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Becton, Dickinson and Company
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Siemens Healthineers AG (Siemens AG)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisitions and Mergers:
10.3.5.3 Geographical Expansions:
10.3.6 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Product Launches and Product Expansions:
10.5 Koninklijke Philips N.V.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 F. Hoffmann-La Roche Ltd.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.7 Qiagen N.V.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Product Launches and Product Expansions:
10.8 Bio-Rad laboratories, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Product Launches and Product Expansions:
10.9 Danaher Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisitions and Mergers:
10.10. Quidel Corporation
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Approvals & Trails:

TABLE 1 North America Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 North America Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Infectious Respiratory Disease Diagnostics Market
TABLE 4 Product Launches And Product Expansions– Infectious Respiratory Disease Diagnostics Market
TABLE 5 Acquisition and Mergers– Infectious Respiratory Disease Diagnostics Market
TABLE 6 Geographical Expansion– Infectious Respiratory Disease Diagnostics Market
TABLE 7 Approval & TRAILS – Infectious Respiratory Disease Diagnostics Market
TABLE 8 North America Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 9 North America Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 10 North America Consumables Market by Country, 2018 - 2021, USD Million
TABLE 11 North America Consumables Market by Country, 2022 - 2028, USD Million
TABLE 12 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 13 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 14 North America Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 15 North America Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 16 North America Imaging Tests Market by Country, 2018 - 2021, USD Million
TABLE 17 North America Imaging Tests Market by Country, 2022 - 2028, USD Million
TABLE 18 North America Respiratory Measurement Devices Market by Country, 2018 - 2021, USD Million
TABLE 19 North America Respiratory Measurement Devices Market by Country, 2022 - 2028, USD Million
TABLE 20 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 21 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 22 North America Services Market by Country, 2018 - 2021, USD Million
TABLE 23 North America Services Market by Country, 2022 - 2028, USD Million
TABLE 24 North America Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 25 North America Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 26 North America SARS/COVID 19 Market by Country, 2018 - 2021, USD Million
TABLE 27 North America SARS/COVID 19 Market by Country, 2022 - 2028, USD Million
TABLE 28 North America Influenza Market by Country, 2018 - 2021, USD Million
TABLE 29 North America Influenza Market by Country, 2022 - 2028, USD Million
TABLE 30 North America RSV (Respiratory Syncytial Virus) Market by Country, 2018 - 2021, USD Million
TABLE 31 North America RSV (Respiratory Syncytial Virus) Market by Country, 2022 - 2028, USD Million
TABLE 32 North America Tuberculosis Market by Country, 2018 - 2021, USD Million
TABLE 33 North America Tuberculosis Market by Country, 2022 - 2028, USD Million
TABLE 34 North America Streptococcus Testing Market by Country, 2018 - 2021, USD Million
TABLE 35 North America Streptococcus Testing Market by Country, 2022 - 2028, USD Million
TABLE 36 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 37 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 38 North America Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 39 North America Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 40 North America Saliva Market by Country, 2018 - 2021, USD Million
TABLE 41 North America Saliva Market by Country, 2022 - 2028, USD Million
TABLE 42 North America Anterior Nasal Region Market by Country, 2018 - 2021, USD Million
TABLE 43 North America Anterior Nasal Region Market by Country, 2022 - 2028, USD Million
TABLE 44 North America Blood Market by Country, 2018 - 2021, USD Million
TABLE 45 North America Blood Market by Country, 2022 - 2028, USD Million
TABLE 46 North America Nasopharyngeal Swabs (NPS) Market by Country, 2018 - 2021, USD Million
TABLE 47 North America Nasopharyngeal Swabs (NPS) Market by Country, 2022 - 2028, USD Million
TABLE 48 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 49 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 50 North America Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 51 North America Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 52 North America Molecular Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 53 North America Molecular Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 54 North America Microbiology Market by Country, 2018 - 2021, USD Million
TABLE 55 North America Microbiology Market by Country, 2022 - 2028, USD Million
TABLE 56 North America Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 57 North America Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 58 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 59 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 60 North America Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 61 North America Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 62 North America Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 63 North America Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 64 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 65 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 66 North America Physician Offices & Others Market by Country, 2018 - 2021, USD Million
TABLE 67 North America Physician Offices & Others Market by Country, 2022 - 2028, USD Million
TABLE 68 North America Infectious Respiratory Disease Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 69 North America Infectious Respiratory Disease Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 70 US Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 71 US Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 72 US Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 73 US Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 74 US Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 75 US Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 76 US Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 77 US Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 78 US Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 79 US Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 80 US Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 81 US Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 82 US Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 83 US Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 84 Canada Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 85 Canada Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 86 Canada Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 87 Canada Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 88 Canada Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 89 Canada Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 90 Canada Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 91 Canada Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 92 Canada Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 93 Canada Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 94 Canada Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 95 Canada Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 96 Canada Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 97 Canada Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 98 Mexico Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 99 Mexico Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 100 Mexico Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 101 Mexico Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 102 Mexico Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 103 Mexico Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 104 Mexico Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 105 Mexico Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 106 Mexico Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 107 Mexico Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 108 Mexico Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 109 Mexico Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 110 Mexico Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 111 Mexico Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 112 Rest of North America Infectious Respiratory Disease Diagnostics Market, 2018 - 2021, USD Million
TABLE 113 Rest of North America Infectious Respiratory Disease Diagnostics Market, 2022 - 2028, USD Million
TABLE 114 Rest of North America Infectious Respiratory Disease Diagnostics Market by Product Type, 2018 - 2021, USD Million
TABLE 115 Rest of North America Infectious Respiratory Disease Diagnostics Market by Product Type, 2022 - 2028, USD Million
TABLE 116 Rest of North America Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2018 - 2021, USD Million
TABLE 117 Rest of North America Infectious Respiratory Disease Diagnostics Market by Instruments Type, 2022 - 2028, USD Million
TABLE 118 Rest of North America Infectious Respiratory Disease Diagnostics Market by Application, 2018 - 2021, USD Million
TABLE 119 Rest of North America Infectious Respiratory Disease Diagnostics Market by Application, 2022 - 2028, USD Million
TABLE 120 Rest of North America Infectious Respiratory Disease Diagnostics Market by Sample Type, 2018 - 2021, USD Million
TABLE 121 Rest of North America Infectious Respiratory Disease Diagnostics Market by Sample Type, 2022 - 2028, USD Million
TABLE 122 Rest of North America Infectious Respiratory Disease Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 123 Rest of North America Infectious Respiratory Disease Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 124 Rest of North America Infectious Respiratory Disease Diagnostics Market by End-use, 2018 - 2021, USD Million
TABLE 125 Rest of North America Infectious Respiratory Disease Diagnostics Market by End-use, 2022 - 2028, USD Million
TABLE 126 Key Information – Abbott Laboratories
TABLE 127 Key information – Becton, Dickinson and Company
TABLE 128 Key Information – Siemens Healthineers AG
TABLE 129 Key Information – Thermo Fisher Scientific, Inc.
TABLE 130 Key Information – Koninklijke Philips N.V.
TABLE 131 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 132 Key Information – Qiagen N.V.
TABLE 133 Key Information – Bio-Rad Laboratories, Inc.
TABLE 134 Key Information – Danaher Corporation
TABLE 135 key information – Quidel Corporation

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2020, Mar – 2022, Jun) Leading Players
FIG 5 Recent strategies and developments: Abbott Laboratories
FIG 6 Swot analysis: Abbott laboratories
FIG 7 Recent strategies and developments: Becton, Dickinson and Company
FIG 8 Swot analysis: Becton, Dickinson and company
FIG 9 Recent strategies and developments: Siemens Healthineers AG
FIG 10 Swot analysis: Siemens AG
FIG 11 Recent strategies and developments: Thermo Fisher Scientific, Inc.